Instrumental variable estimation of early treatment effect in randomized screening trials
From MaRDI portal
Publication:2074076
DOI10.1007/S10985-021-09527-3OpenAlexW3181303728MaRDI QIDQ2074076
Zhihui Liu, Olli Saarela, Sudipta Saha
Publication date: 4 February 2022
Published in: Lifetime Data Analysis (Search for Journal in Brave)
Full work available at URL: https://arxiv.org/abs/2005.07322
Applications of statistics to biology and medical sciences; meta analysis (62P10) Survival analysis and censored data (62Nxx)
Uses Software
Cites Work
- Does Cox analysis of a randomized survival study yield a causal treatment effect?
- Causal proportional hazards models and time-constant exposure in randomized clinical trials
- Estimating case-fatality reduction from randomized screening trials
- Inference for the Effect of Treatment on Survival Probability in Randomized Trials with Noncompliance and Administrative Censoring
- A Causal Proportional Hazards Estimator for the Effect of Treatment Actually Received in a Randomized Trial with All-or-Nothing Compliance
- Competing Risks and Multistate Models with R
- Identification of Causal Effects Using Instrumental Variables
- Optimal scheduling of examinations for the early detection of disease
- Identification and Estimation of Local Average Treatment Effects
- Planning clinical trials to evaluate early detection programmes
- Correcting for non-compliance in randomized trials using structural nested mean models
- Latent Subgroup Analysis of a Randomized Clinical Trial through a Semiparametric Accelerated Failure Time Mixture Model
- Parametric estimation procedures for screening programmes: stable and nonstable disease models for multimodality case finding
- Uses and limitations of randomization-based efficacy estimators
- A Conditional Approach to Measure Mortality Reductions Due to Cancer Screening
This page was built for publication: Instrumental variable estimation of early treatment effect in randomized screening trials
